5-Benzyloxytryptamine

5-Benzyloxytryptamine (5-BT) is a selective partial agonist of the 5-hydroxytryptamine 1D/1B (5-HT1D/1B) receptors, with an IC50 value of 40 nM for the bovine caudate nucleus 5-HT1D. It exhibits much lower affinity for other receptors (5-HT2 IC50 > 470 nM) . 5-Benzyloxytryptamine inhibits adenylate cyclase, leading to reduced neurotransmitter release and downregulation of cAMP signaling. It holds potential for research into diseases associated with neurotransmitter imbalances.